While insulin resistance is known to underlie type 2 diabetes, its role in the development of type 1 diabetes is gaining increasing interest more recently. In a model of type 1 diabetes, the non-obese diabetic (NOD) mouse, we found that insulin resistance driven by lipid-and glucose-independent mechanisms is already present in liver of pre-diabetic mice. Hepatic insulin resistance is associated with a transient rise in mitochondrial respiration, followed by increased production of lipid peroxides and c-jun N-terminal kinase (JNK) activity. At the onset of diabetes, increased adipose tissue lipolysis promotes myocellular diacylglycerol accumulation. This is paralleled by increased myocellular protein kinase C theta (PKCθ) activity and serum fetuin A levels. Muscle mitochondrial oxidative capacity is unchanged at the onset, but decreases at later stages of diabetes. In conclusion, hepatic and muscle insulin resistance manifest at different stages and involve distinct cellular mechanisms during the development of diabetes in the NOD mouse.
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Insulin resistance is not only a feature of obesity and type 2 diabetes mellitus (T2DM), but can also be present in patients with type 1 diabetes mellitus (T1DM) (1; 2), resulting in a condition termed 'double diabetes'. T1DM is characterized by absolute insulin deficiency due to autoimmune-mediated β-cell destruction (3), leading to uncontrolled glucose homeostasis.
Although insulin resistance in T1DM may occur independently, the accelerator hypothesis postulates that it can be triggered by autoimmune diabetes itself (4) . The causes and mechanisms linking T1DM and insulin resistance remain still unknown.
Prolonged hyperglycemia may induce insulin resistance by mechanisms summarized as glucotoxicity (5) . On the other hand, insulin deficiency also decreases the suppression of lipolysis in adipose tissue and liver, thereby raising circulating triglycerides (TG) and fatty acids (FA). This can in turn impair insulin-stimulated glucose transport by various mechanisms summarized as lipotoxicity (6; 7) . Both the diacylglycerol (DAG)/protein kinase C isoforms (nPKC) pathway (6) as well as toll-like receptor 4 (TLR4)/fetuin A-mediated ceramide synthesis (8) have been shown to inhibit insulin signaling.
Furthermore, glucotoxicity and lipotoxicity strongly associate with lower mitochondrial function. In muscle, lower mitochondrial activity frequently associates with insulin resistance in humans with or at risk of T2DM (9; 10). Insulin deprivation can also reduce muscle mitochondrial ATP production by altered expression of mitochondrial genes (11) , and insulin resistant patients with long-lasting T1DM may have lower flux to ATP synthase (1) . Recent studies show that reduced hepatic energy metabolism also correlates with insulin resistance, hyperglycemia and altered hepatic lipid content in T2DM (12; 13). However, others questioned the role of mitochondrial function for insulin resistance (14) . The contribution of mitochondrial function to insulin resistance has not yet been clarified in T1DM.
We hypothesized that the onset of T1DM is associated with impaired insulin sensitivity and lower mitochondrial function. While glucolipotoxicity may cause insulin resistance in the liver, muscle insulin resistance may develop independent of ambient glycemia. To test this hypothesis, we examined diabetes-related effects in female non-obese diabetic (NOD) mice independently of other confounding factors such as gender, obesity, ageing and inherited mitochondrial abnormalities.
Research Design and Methods

Animals
NOD and wild-type C57BL6 (WT) mice were maintained under specific pathogen-free conditions on a 12-h light-dark cycle and received a standard rodent diet (Ssniff M-Z Extrudat, 4.5% fat; SSNIFF Spezialdiäten GmbH, Soest, Germany) and water ad libitum. We studied only female mice, because 80% of female but only 30% of male NOD develop diabetes within 30 weeks of age (15) . Experiments were performed three days (acute diabetic NOD, A-DM) or 8 weeks after onset of diabetes (insulin-treated chronic diabetic NOD, C-DM) in randomly assigned mice. Non-diabetic NOD (N-DM) mice were matched for age and body weight. Mice were studied in the fed state and after 6 hours of fasting. Insulin-treated C-DM were only examined in the fed state to avoid hypoglycemia. After decapitation, trunk blood and tissues were collected, weighed and used for high-resolution respirometry or snapfrozen in liquid nitrogen. All experiments were performed according to the guidelines for care and use of animals (GV-SOLAS, Society for Laboratory Animal Science) and approved by the local council of animal care in line with the requirements of the German animal protection act.
Detection and treatment of hyperglycemic NOD mice
Diabetes was detected by testing for glycosuria (Diabur-test 5000, Roche Diagnostics, Mannheim, Germany) and confirmed by tail blood glucose measurements >250 mg/dl on two consecutive days (Precision Xtra Plus, Abbott, Wiesbaden, Germany). Insulin was administered subcutaneously in LinBit pellets (LinShin Canada, Toronto, Canada) for 8 weeks aiming to maintain blood glucose between 250 and 500 mg/dl. At glucose >500 mg/dl for more than one week, an additional insulin pellet was administered.
Indirect calorimetry
Mice were individually housed and placed in an 8-chamber indirect calorimetry system (PhenoMaster; TSE Systems, Bad Homburg, Germany). After 24 hours of acclimatization, energy expenditure, respiratory quotient (RQ), physical activity, food and water intake were simultaneously analyzed for 48 hours. (16) . After the clamps, mice were exsanguinated through cervical incision, sacrificed by cervical dislocation and serum and organs collected for analyses.
Hyperinsulinemic-euglycemic clamp test
High-resolution respirometry
Ex vivo mitochondrial function was measured in fresh liver and gastrocnemius muscle using the Oxygraph-2k (Oroboros Instruments, Austria) as described (17 
Mitochondrial density
Tissue DNA was extracted with Qiagen Tissue and Blood Kit (Qiagen, Hilden; Germany) and concentration measured spectrophotometrically (GeneQuant, GE Healthcare, Munich, The ratio of mtDNA to nuclear DNA is a measure of tissue concentration of mtDNA per cell. 
Laboratory analyses
Assessment of lipid peroxidation
Tissue concentrations of thiobarbituric acid-reactive substances (TBARS) were measured fluorometrically (BioTek, Bad Friedrichshall, Germany) in 10 mg of frozen gastrocnemius muscle and liver (18) . Protein content in homogenates was assessed with the bicinchoninic acid assay (BCA protein kit, Thermo Fisher Scientific, Bonn, Germany).
Insulin signaling ex vivo
Mice were intraperitoneally injected with insulin (1 U/kg body weight) or saline (control), euthanized after 10 min, and, liver and muscle tissues were snap-frozen in liquid nitrogen.
RNA and protein analyses
Total RNA extraction, cDNA synthesis and real time qRT-PCR expression analyses were performed as described (19) . Data of gene specific probes (Assay on Demand ™ , Applied
Biosystems, Darmstadt, Germany) were normalized to 18S RNA content (19) .
Proteins were extracted by homogenization and centrifugation ( 
Quantification of lipids
Oil red O (ORO) staining was performed in fresh right liver lobe fixed in 4%
paraformaldehyde (21) . Stained sections were examined using light microscopy at 40fold magnification (Leica DMRBE, Wetzlar, Germany). Liver and muscle samples were solubilized in ethanolic KOH and glycerolipids measured as described (22) using a TG standard (Lyonorm Calibrator, Pliva-Lachema Diagnostika, Brno, Czech Republic).
Myocellular lipid metabolites
Membrane and cytosol fractions were extracted by homogenization and centrifugation (52) and DAGs and ceramides measured by LC-MS (23).
Immunohistochemistry
Pancreas tissue was embedded in paraffin, stained by hematoxylin/eosin and examined with light microsopy (24) . For β-cell and α-cell detection, double immunofluorescence staining was performed using anti-insulin and anti-glucagon antibodies (DAKO, Hamburg, Germany), respectively. Images were acquired using inverted microscope (Leica, Wetzlar, Germany) and digital camera (Olympus Europa, Hamburg, Germany).
Calculations and statistical analyses
Glucose disposal (Rd) was calculated by Steele's single-pool non-steady-state equations (25) .
Endogenous glucose production (EGP) is given as the difference between Rd and glucose infusion rate.
Surrogate indexes of insulin sensitivity and secretion were calculated from fasting blood glucose (G) and serum insulin (I) levels: quantitative insulin check index of insulin sensitivity 
Results
Both diabetic and non-diabetic NOD mice are insulin resistant
Body weight was similar among A-DM, N-DM and C-DM and slightly higher than in WT mice (Table 1 ). In the fed state, blood glucose was 4-fold higher in A-DM and C-DM, versus N-DM and WT (Table S1 ). Insulin levels were lower in A-DM compared to N-DM (Table 1) .
During fasting, circulating glucose, TG and FA were increased in A-DM compared to N-DM and WT (Fig. 1A ,B,C). QUICKI was 13% and 9% lower in A-DM and N-DM, than in WT, suggesting glucose-independent insulin resistance in the NOD model (Table 1) . HOMA-B was 3.5-and 5.5-fold higher in N-DM compared to WT and A-DM, fitting with the previous observation that prediabetic NOD mice have higher in vivo and ex vivo glucose-stimulated insulin secretion as compared to C57BL6 mice (28) . A-DM had lower HOMA-B and insulin levels in fed state compared to N-DM, illustrating the impaired β-cell function, which is due to severe insulitis (data not shown) typical for the NOD model (24) .
Diabetic NOD mice lose fat mass and rely on fat oxidation
A-DM had substantially (60-75%) lower visceral and subcutaneous fat masses (Fig. S1A,B ).
Muscle TG was unchanged except for a small increase in ad libitum-fed N-DM (Fig. S1C ).
Liver weight was comparable between groups, while hepatic TG was lower in fasted A-DM (Fig. S1A ,B,C,D and Fig. S2 ).
Only WT and N-DM displayed normal diurnal energy expenditure patterns ( Fig. 2A,B) . A-DM showed a shift in RQ to 0.81 with preferential lipid oxidation (Fig. 2C,D) , which was supported by a trend towards higher serum β-hydroxybutyrate levels (0.62±0.22 versus N-DM: 0.25±0.07 mmol/l, p=0.083). Finally, A-DM exhibited lower physical activity during the dark cycle (Fig. 2D ) and increased overall food and water intake (Fig. 2F,G) . Energy expenditure was similar among groups (Fig. 2H ).
Diabetic and non-diabetic NOD mice show tissue-dependent differences in insulin sensitivity
During the hyperinsulinemic-euglycemic clamps, steady-state blood glucose (Fig. 3A ) and serum insulin (not shown) were comparable. A-DM had higher fasting EGP versus WT and N-DM (Fig. 3B) . In A-DM, EGP was positively related to fasting glycemia (r=0.95, p<0.05, n=9). Both A-DM and N-DM displayed lower insulin-mediated suppression of EGP versus WT (Fig. 3C ) indicating hepatic insulin resistance. A-DM showed impaired insulin-stimulated Rd, which was 62% and 66% reduced compared to WT and N-DM (Fig. 3D) . Uptake of 2-deoxy-glucose by gastrocnemius and soleus muscles was also lower in A-DM (Fig. 3E,F) . In A-DM, plasma FA decreased similary as in WT and N-DM during the first 15 min, but remained higher from the 30 min to the end of the clamp (Fig. 2G) . Overall percent suppression of FA in A-DM was comparable to N-DM (Fig. 2H) suggesting intact insulin sensitivity of adipose tissue.
Diabetic and non-diabetic NOD mice show lower fasting muscle mitochondrial oxidation, but increased lipid peroxidation in the fed state
In the fed state, complex I (CI) respiration was decreased by 38% in C-DM (Fig. 4A ). During fasting, CI+CII and maximal ETS capacities were decreased by ~20% in A-DM and N-DM (Fig. 4B ). Results were normalized to mtDNA copy number, which did not differ between groups (not shown). Differences in mitochondrial respiration did not associate with changes in gene expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), mitochondrial transcription factor A (TFAM) nor nuclear respiratory factor-1 (NRF-1) (Fig. 4C,D) .
Measurement of TBARS in the muscle revealed that WT, unlike N-DM or A-DM, have lower lipid peroxides in the fed compared to fasting state, (p<0.01, Fig. S1E,F) . Moreover, fed N-DM, A-DM and C-DM mice had higher TBARS than WT (Fig. S1E) .
Diabetic NOD mice show increased PKCθ-mediated serine phosphorylation of IRS1 in gastrocnemius muscle
Upon intraperitoneal insulin injection, A-DM displayed reduced basal levels of insulin receptor (IR, -32%) and insulin receptor substrate-1 (IRS-1, -30%) in muscle compared to WT (Fig. 5A,B) . Serine phosphorylation of IRS1 was increased by 149% at Ser1101 and by 246%
at Ser307 (Fig. 5C,D) . A-DM showed profoundly decreased insulin-stimulated membrane-tocytosol ratio of Akt (-61%, Fig. 5E ) and glucose transporter 4 (GLUT4, -76%, Fig. 5F ). N-DM had reduced IR and intermediate decreases in Akt and GLUT4 membrane-to-cytosol ratio (Fig. 5A ,E,F).
Levels of pERK-Thr202/Tyr204, p-p38-Thr180/Tyr182, pIκB-Ser32 (Fig. S3 ) and pNFκB-Ser536 (Fig. 5I) were unchanged. Phosphorylation of JNK at Thr183 and Tyr186 was increased in A-DM and N-DM (Fig. 5H) . Only the higher membrane-to-cytosol ratio of PKCθ clearly associated with decreases in peripheral insulin sensitivity in A-DM (+148% versus WT, +53% versus N-DM, Fig 5G) .
A-DM had higher membrane-to-cytosol DAGs (Fig. 6A ) due to changes in several specific DAG species (Fig. 6B) . Neither total nor individual species of ceramides were different between the groups (Fig. 6C,D) .
NOD mice have increased hepatic lipid peroxidation, but only diabetic NOD mice show augmented hepatic mitochondrial oxidation
In the fed state, hepatic O 2 flux rates through CI, CI+CII and maximal ETS capacity were increased in A-DM compared to N-DM and WT (Fig. 4E) . In C-DM, CI and CI+CII respiration was increased versus WT, but lower versus A-DM (Fig. 4E) . No differences were observed in the fasted state (Fig. 4F) . Hepatic mtDNA copy number was similar among all groups (not shown).
In contrast to muscle, increased respiration in the liver of A-DM was accompanied by higher transcription of PGC-1α TFAM and NRF1 compared to N-DM and WT (Fig. 4G ).
Hepatic TBARS were unchanged in the fasted state, but higher in fed N-DM, A-DM (Fig.   S1E ,F) and even more pronounced in C-DM. Similar to muscle, hepatic TBARS decreased during feeding in WT only (p<0.001).
JNK signaling is increased in the liver of NOD mice
Protein abundance of hepatic IR, IRS-2 (Fig. 5J,K) , and IRS-1 (not shown) were similar in all groups. However, A-DM had 125% and 74% higher levels of phosphorylated IRS1 at Ser1101 and at Ser307 than WT at baseline (Fig. 5L,M) . N-DM mice also showed 137%
higher IRS1 phosphorylation at Ser1101 (Fig. 5L ). Insulin-stimulated translocation of Akt to the membrane was suppressed by 76% in A-DM and to a lesser extent (by 40%) in N-DM (Fig. 5N) .
Levels of pERK-Thr202/Tyr204, p-p38-Thr180/Tyr182, IκB, pIκB-Ser32 (Fig. S4 ) and pNFκB-Ser536 (Fig. 5R) were unchanged. Intriguingly, the membrane-to-cytosol ratio of PKCε was 36% and 27% lower in A-DM and N-DM, respectively (Fig. 5O) . This was exclusively due to an increase in PKCε in the cytosolic fraction (Fig. 5P) . Importantly, phosphorylation of JNK at Thr183 and Tyr186 was increased by 64% in A-DM and by 67%
in N-DM (Fig. 5Q ) rendering pJNK as the only factor associated with changes in hepatic insulin sensitivity.
Circulating fetuin A levels are increased in NOD mice
In A-DM and N-DM, fasting serum concentrations of fetuin A were 2.0-and 2.9-fold higher than in WT (Fig. 1D) .
Discussion
This study describes the early metabolic events occurring before and at the onset of insulin- (49) and overall mitochondrial respiration (50) . Importantly, upregulated hepatic mitochondrial oxidative capacity seems to be transient, as it declines in C-DM. Similar to muscle, this could be a consequence of mitochondrial damage due to lipid peroxide accumulation.
In conclusion, insulin resistance in a murine non-obese model of T1DM develops in the liver before the onset of diabetes and associates with increased oxidative stress and pJNK, as possible cellular mediators. Muscle insulin sensitivity is impaired already three days after the onset of diabetes and accompanied by increased levels of DAG, PKCθ and serum fetuin A.
Furthermore, mitochondrial oxidative capacity is transiently enhanced in the liver and declines in muscle with longer disease duration. Knowledge of these mechanisms could help to develop new strategies to prevent and treat insulin resistance and subsequent complications in patients with type 1 diabetes. 
